Anthropic has built a dedicated biology laboratory to develop AI-driven drug treatments specifically targeting rare diseases. The new facility marks a strategic expansion into biotechnology, leveraging artificial intelligence to accelerate therapeutic discovery and development. The initiative aims to apply advanced AI models to biological research, focusing on creating novel treatments for underserved patient populations with rare medical conditions. This move positions the company at the intersection of artificial intelligence and pharmaceutical innovation.